Sildenafil ameliorates effects of inhaled nitric oxide withdrawal

Anesthesiology

Volumn 91, Issue 1, 1999, Pages 307-310

  Andrew, M Atz ^b   Wessel, David L ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NONE

Author keywords

Congenital heart disease; Cyclic guanosine monophosphate; Phosphodiesterase inhibition; Pulmonary hypertension; Rebound pulmonary hypertension

Indexed keywords

NITRIC OXIDE; PHOSPHODIESTERASE; SILDENAFIL;

ARTICLE; CASE REPORT; CONGENITAL HEART DISEASE; DOSE RESPONSE; DRUG MECHANISM; DRUG MIXTURE; DRUG POTENTIATION; FEMALE; HUMAN; HYPERTENSION; INFANT; INHALATIONAL DRUG ADMINISTRATION; MALE; NASOGASTRIC TUBE; NEGATIVE FEEDBACK; PEDIATRIC SURGERY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REBOUND; RESPIRATORY FAILURE;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ADMINISTRATION, INHALATION; CYCLIC GMP; FEMALE; HUMANS; HYPERTENSION, PULMONARY; INFANT; INFANT, NEWBORN; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0344258463     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199907000-00041     Document Type: Article

References (12)

1. Sanchez LS, de la Monte SM, Filippov G, Jones RC, Zapol WM, Bloch KD: Cyclic-GMP-binding, cyclic-GMP-specific phosphodiesterase (PDE5) gene expression is regulated during rat pulmonary development. Pediatr Res 1998; 43:163-8
2. Ivy DD, Kinsella JP, Ziegler JW, Abman SH: Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease. J Thorac Cardiovasc Surg 1998; 115:875-82
3. Boolell M, Gepi-Attee S, Gingell JC, Allen MJ: Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br J Urol 1996; 78:257-61
4. Goldman AP, Haworth SG, Macrae DJ: Does inhaled nitric oxide suppress endogenous nitric oxide production? J Thorac Cardiovasc Surg 1996; 112:541-2
5. Buga GM, Griscavage JM, Rogers NE, Ignarro LJ: Negative feedback regulation of endothelial cell function by nitric oxide. Circ Res 1993; 73:808-12
6. Assreuy J, Cunha FQ, Liew FY, Moncada S: Feedback inhibition of nitric oxide synthase activity by nitric oxide. Eur J Pharmacol 1993; 108:833-7
7. Ravichandran LV, Johns RA, Rengasamy A: Direct and reversible inhibition of endothelial nitric oxide synthase by nitric oxide. Am J Physiol 1995; 268:H2216-23
8. Gerlach H, Rossaint R, Pappert D, Knorr M, Falke KJ: Autoinhalation of nitric oxide after endogenous synthesis in nasopharynx. Lancet 1994; 343:518-9
9. Ichinose F, Adrie C, Hurford W, Zapol W: Prolonged pulmonary vasodilator action of inhaled nitric oxide by zaprinast in awake lambs. J Appl Physiol 1995; 78:1288-95
10. Dukarm RC, Morin FC, Russell JA, Steinhorn RH: Pulmonary and systemic effects of the phosphodiesterase inhibitor dipyridamole in newborn lambs with persistent pulmonary hary arteion. Pediatr Res 1998; 44:831-7
11. Black SM, Heidersbach RS, McMullan DM, Fineman JR: Inhaled nitric oxide inhibits NOS activity in lambs: A potential mechanism for rebound pulmonary hypertension (abstract). Crit Care Med 1999: 27:A39
12. Atz AM, Adatia I, Wessel DL: Rebound pulmonary hypertension after inhalation of nitric oxide. Ann Thorac Surg 1996; 62:1759-64